HomeCompareKBSTF vs MRK

KBSTF vs MRK: Dividend Comparison 2026

KBSTF yields 5.53% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBSTF wins by $10955.36M in total portfolio value
10 years
KBSTF
KBSTF
● Live price
5.53%
Share price
$11.50
Annual div
$0.64
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10955.41M
Annual income
$10,587,660,060.71
Full KBSTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KBSTF vs MRK

📍 KBSTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBSTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBSTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBSTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBSTF
Annual income on $10K today (after 15% tax)
$470.11/yr
After 10yr DRIP, annual income (after tax)
$8,999,511,051.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KBSTF beats the other by $8,999,502,723.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBSTF + MRK for your $10,000?

KBSTF: 50%MRK: 50%
100% MRK50/50100% KBSTF
Portfolio after 10yr
$5477.74M
Annual income
$5,293,834,929.43/yr
Blended yield
96.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KBSTF
No analyst data
Altman Z
1.8
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBSTF buys
0
MRK buys
0
No recent congressional trades found for KBSTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBSTFMRK
Forward yield5.53%2.76%
Annual dividend / share$0.64$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$10955.41M$56.8K
Annual income after 10y$10,587,660,060.71$9,798.13
Total dividends collected$10929.80M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KBSTF vs MRK ($10,000, DRIP)

YearKBSTF PortfolioKBSTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,806$1,106.14$11,206$366.19+$600.00KBSTF
2$15,074$2,440.98$12,650$502.35+$2.4KKBSTF
3$21,954$5,825.29$14,407$694.19+$7.5KKBSTF
4$39,349$15,858.49$16,585$967.82+$22.8KKBSTF
5$95,233$53,128.94$19,342$1,363.89+$75.9KKBSTF
6$342,239$240,340.34$22,913$1,947.19+$319.3KKBSTF
7$1,980,617$1,614,421.38$27,662$2,823.89+$1.95MKBSTF
8$19,582,864$17,463,603.80$34,159$4,173.35+$19.55MKBSTF
9$343,695,836$322,742,171.48$43,337$6,308.80+$343.65MKBSTF
10$10,955,414,606$10,587,660,060.71$56,776$9,798.13+$10955.36MKBSTF

KBSTF vs MRK: Complete Analysis 2026

KBSTFStock

Kobe Steel, Ltd. engages in the materials, machinery, and electric power businesses worldwide. The company offers steel sheet products, including high-tensile strength, hot and cold rolled, electro-galvanized, and hot-dipped galvanized steel sheets; steel wire rods and bars; and aluminum and steel plates. It also provides steel casting and forging products, such as crankshafts, marine parts, chemical processing equipment, and rolls; materials for plastic molding; and titanium products, copper sheets and strips, and steel powders. In addition, the company offers robots and electric power sources, and welding materials; and machinery products, including standard compressors, tire and rubber machinery products, rotating machinery products, plastic processing machinery products, advanced technology equipment, rolling mill products, and ultra-high-pressure equipment, as well as LNG vaporizers, pressure vessels, brazed aluminum heat exchangers, and micro channel heat exchanger and reactors. Further, it provides signaling, communication, power supply, automatic fare collection, and platform screen door systems; hydraulic and mini hydraulic excavators, mini wheel loaders, and road machinery; construction, metal, forestry, and industrial waste recycling machinery; and crawler and wheel cranes. Additionally, the company generates and supplies electric power; offers material and structural analysis, testing, physical analysis, and other services; manufactures and sells target materials and test equipment; sells and rents detached homes; and provides brokerage, renovation, insurance, and other services, as well as operational management services of public facilities. It also provides services in the field of iron units; and water treatment, waste incineration, PCB detoxification, and soil remediation services. The company was founded in 1905 and is headquartered in Kobe, Japan.

Full KBSTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KBSTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBSTF vs SCHDKBSTF vs JEPIKBSTF vs OKBSTF vs KOKBSTF vs MAINKBSTF vs JNJKBSTF vs ABBVKBSTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.